Review
Cytokines as mediators of depression: What can we learn from animal studies?

https://doi.org/10.1016/j.neubiorev.2005.03.023Get rights and content

Abstract

It has recently been postulated that cytokines may cause depressive illness in man. This hypothesis is based on the following observations: 1. Treatment of patients with cytokines can produce symptoms of depression; 2. Activation of the immune system is observed in many depressed patients; 3. Depression occurs more frequently in those with medical disorders associated with immune dysfunction; 4. Activation of the immune system, and administration of endotoxin (LPS) or interleukin-1 (IL-1) to animals induces sickness behavior, which resembles depression, and chronic treatment with antidepressants has been shown to inhibit sickness behavior induced by LPS; 5. Several cytokines can activate the hypothalamo–pituitary–adrenocortical axis (HPAA), which is commonly activated in depressed patients; 6. Some cytokines activates cerebral noradrenergic systems, also commonly observed in depressed patients; 7. Some cytokines activate brain serotonergic systems, which have been implicated in major depressive illness and its treatment. The evidence for each of these tenets is reviewed and evaluated along with the effects of cytokines in classical animal tests of depression. Although certain sickness behaviors resemble the symptoms of depression, they are not identical and each has distinct features. Thus the value of sickness behavior as an animal model of major depressive disorder is limited, so that care should be taken in extrapolating results from the model to the human disorder. Nevertheless, the model may provide insight into the etiology and the mechanisms underlying some symptoms of major depressive disorder. It is concluded that immune activation and cytokines may be involved in depressive symptoms in some patients. However, cytokines do not appear to be essential mediators of depressive illness.

Introduction

In recent years, it has been postulated that depression may be caused by cytokine secretion associated with activation of the immune system. This hypothesis was proposed initially because the incidence of immune abnormalities is higher in depressed patients than in the general population, and because depression is a common side effect of cytokine therapy. The hypothesis gained momentum when it was shown that immune activation and administration to animals of endotoxin (lipopolysaccharide, LPS) or the cytokine, interleukin-1 (IL-1), could induce a behavioral pattern resembling that commonly observed in sick animals, including man. This behavioral pattern has become known as sickness behavior. There are many similarities between sickness behavior and the symptoms of depression. Thus it was suggested that cytokines could induce depression, or indeed were the cause of depression. The hypothesis has come to be called the cytokine hypothesis of depression, although proponents differ on whether cytokines are a cause of major depressive disorder, or the cause.

The cytokine hypothesis of depression posits that depression is caused by the actions of cytokines. Cytokines are proteins and glycoproteins secreted by immune cells that function as signals among and between immune cells. They are the hormones of the immune system. It is now known that cytokines have effects on cells outside the immune system, and that non-immune cells can synthesize and secrete cytokines. Thus cytokines can be regarded as classical hormones that can function locally or systemically to orchestrate immune responses, and can also coordinate immune responses with those of other physiological systems in the body, including the nervous system.

The cytokine hypothesis of depression derives from both clinical and experimental observations. The clinical observations were made on patients treated with interferons (IFN's) and interleukin-2 (IL-2). Such patients often displayed influenza-like symptoms and nonspecific neuropsychiatric symptoms, some of which are characteristics of depression. However, the initial interest was not focused on depression, although depression is a relatively common side-effect. Immune abnormalities in depressed patients have been widely reported for more than 30 years. The earliest studies suggested deficient immune function in depressed patients, but the results were inconsistent and highly variable (see Weisse, 1992). Subsequent studies indicated that depressed patients often exhibited immune activation, and that depression was more frequent in patients with diseases having an immunological component (Kronfol, 2002). However, the results were quite varied; immune function in depressed patients was decreased in some aspects, but activated in others.

The interest in an immune system involvement in depression intensified around 15 years ago with the juxtaposition of the above observations on immune abnormalities in depressed patients with the effects of immune challenges in animals. In the animal studies, it was shown that administration of LPS or IL-1 induced a behavioral syndrome that became known as ‘sickness behavior’ (Kent et al., 1992). Smith first suggested that depression was associated with increased secretion of cytokines (especially IL-1) by macrophages (Smith, 1991). He noted that administration of IL-1 mimicked not only some of the behavioral characteristics of depression, but also activated the hypothalamo–pituitary–adrenocortical axis (HPAA). This macrophage hypothesis of depression attracted immediate attention, because it was compatible with a number of earlier findings in depressed patients.

Section snippets

Experimental evidence for the cytokine hypothesis of depression

The experimental evidence for the cytokine hypothesis of depression is summarized in Table 1. Each of these points will be reviewed in turn, focusing on the evidence from animal models.

Effects of immune activation and cytokines in classical tests of depression

The cytokine hypothesis of depression would be strengthened if immune stimulation or cytokine administration proved positive in classical models of depression. Generally, these models are based on the assumption that a particular behavioral pattern resembles a human depressive symptom, and/or it is selectively sensitive to clinically effective antidepressant treatments. The most recent reviews indicate that there are some half dozen rodent models of depression (Cryan et al., 2002, Cryan and

Conclusions

The above review indicates some associations between the appearance of cytokines and major depressive disorder. However, no clear causal relationship has been established. Administration of certain cytokines to humans (especially IFNα and IL-2) induces symptoms of depression in some patients, but such responses occur in only a minority of patients, and many other neuropsychiatric symptoms may also be induced. Immune activation appears more frequently in depressed patients than in the general

Acknowledgements

The authors' research included or referred to in this article was supported by the US National Institutes of Health (MH46261 and NS35370), and by the EU Framework 6 NEWMOOD Integrated Project and the Polish Committee for Scientific Research, (KBN) Grant 3 PO 4C05825. We thank Christina A. Meyers, PhD (University of Texas MD Anderson Cancer Center) for suggestions for improving the manuscript.

References (193)

  • N. Castanon et al.

    Chronic treatment with the antidepressant tianeptine attenuates lipopolysaccharide-induced Fos expression in the rat paraventricular nucleus and HPA axis activation

    Psychoneuroendocrinology

    (2003)
  • B.G. Charlton

    The malaise theory of depression: major depressive disorder is sickness behavior and antidepressants are analgesic

    Med. Hypotheses

    (2000)
  • S. Cheeta et al.

    Changes in sleep architecture following chronic mild stress

    Biol. Psychiatr.

    (1997)
  • J.F. Cryan et al.

    Assessing antidepressant activity in rodents: recent developments and future needs

    Trends Pharmacol. Sci.

    (2002)
  • T. Deak et al.

    Exposure to forced swim stress does not alter central production of IL-1

    Brain Res.

    (2003)
  • R. De La Garza et al.

    The non-steroidal anti-inflammatory drug diclofenac sodium attenuates IFN-α induced alterations to monoamine turnover in prefrontal cortex and hippocampus

    Brain Res.

    (2003)
  • S. del Cerro et al.

    Interleukin-1 affects the behavioral despair response in rats by an indirect mechanism which requires endogenous CRF

    Brain Res.

    (1990)
  • P.L. Delgado et al.

    Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action

    Biol. Psychiatr.

    (1999)
  • B. Dubrovsky

    Evolutionary psychiatry. Adaptationist and nonadaptationist conceptualizations

    Prog. Neuropsychopharmacol. Biol. Psychiatry

    (2002)
  • D.S. Duch et al.

    Urinary excretion of biopterin and neopterin in psychiatric disorders

    Psychiatr. Res.

    (1984)
  • A.J. Dunn

    Systemic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism parallelling the increased plasma corticosterone

    Life Sci.

    (1988)
  • A.J. Dunn

    The role of interleukin-1 and tumor necrosis factor α in the neurochemical and neuroendocrine responses to endotoxin

    Brain Res. Bull.

    (1992)
  • A.J. Dunn et al.

    The role of cyclo-oxygenase and lipoxygenase in the interleukin-1-induced activation of the HPA axis: dependence on the route of injection

    Life Sci.

    (1992)
  • A.J. Dunn et al.

    Behavioral responses to stress are intact in CRF-deficient mice

    Brain Res.

    (1999)
  • A.J. Dunn et al.

    The role of cyclooxygenases in endotoxin- and interleukin-1-induced hypophagia

    Brain Behav. Immun.

    (2000)
  • M. Fleshner et al.

    Interleukin-1β induced corticosterone elevation and hypothalamic NE depletion is vagally mediated

    Brain Res. Bull.

    (1995)
  • N.F. Forbes et al.

    Chronic mild stress and sucrose consumption: validity as a model of depression

    Physiol. Behav.

    (1996)
  • Z. Gorka et al.

    Effect of chronic mild stress on circadian rhythms in the locomotor activity in rats

    Pharmacol. Biochem. Behav.

    (1996)
  • J. Griffiths et al.

    Neuroendocrine measures and lymphocyte subsets in depressive illness: influence of a clinical interview concerning life experiences

    Psychoneuroendocrinology

    (1997)
  • M. Haack et al.

    Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis

    J. Psychiatr. Res.

    (1999)
  • F. Haour et al.

    Brain Interleukin-1 receptors: mapping, characterization and modulation

  • B.L. Hart

    Biological basis of the behavior of sick animals

    Neurosci. Biobehav. Rev.

    (1988)
  • A.L.O. Hebb et al.

    Self-stimulation from the mesencephalon following intraventricular interleukin-2 administration

    Brain Res. Bull.

    (1998)
  • F. Holsboer et al.

    Acute adrenocortical stimulation by recombinant gamma interferon in human controls

    Life Sci.

    (1988)
  • I. Huitinga et al.

    IL-1β immunoreactive neurons in the human hypothalamus: Reduced numbers in multiple sclerosis

    J. Neuroimmunol.

    (2000)
  • A. Kabiersch et al.

    Interleukin-1 induces changes in norepinephrine metabolism in the rat brain

    Brain Behav. Immun.

    (1988)
  • M. Kamata et al.

    Effect of single intracerebroventricular injection of α-interferon on monoamine concentrations in the rat brain

    Eur. Neuropsychopharmacol.

    (2000)
  • J.P. Kelly et al.

    The olfactory bulbectomized rat as a model of depression: an update

    Pharmacol. Therap.

    (1997)
  • S. Kent et al.

    Sickness behavior as a new target for drug development

    Trends Pharmacol. Sci.

    (1992)
  • S. Kent et al.

    Reduction in food and water intake induced by microinjection of interleukin-1β in the ventromedial hypothalamus of the rat

    Physiol. Behav.

    (1994)
  • M. Kubera et al.

    The effect of mild chronic stress, as a model of depression, on the immunoreactivity of C57BL/6J mice

    Int. J. Immunopharmacol.

    (1998)
  • T.T.T. Kumai et al.

    Effect of interferon-alpha on tyrosine hydroxylase and catecholamine levels in the brain of rats

    Life Sci.

    (2000)
  • R. Landmann et al.

    Unaltered monocyte function in patients with major depression before and after three months of antidepressive therapy

    Biol. Psychiatr.

    (1997)
  • S.J. Larson et al.

    Behavioral effects of cytokines

    Brain Behav. Immun.

    (2001)
  • S.J. Larson et al.

    Effects of interleukin-1β on food-maintained behavior in the mouse

    Brain Behav. Immun.

    (2002)
  • S. Layé et al.

    Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice

    Mol. Brain Res.

    (1994)
  • R.M. Lechan et al.

    Immunoreactive interleukin-1B localization in the rat forebrain

    Brain Res.

    (1990)
  • T. Ando et al.

    Mouse tumor necrosis factor-α increases brain tryptophan concentrations and norepinephrine metabolism while activating the HPA axis in mice

    Neuroimmunomodulation

    (1999)
  • H. Anisman et al.

    Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features

    Mol. Psychiatr.

    (1999)
  • R. Avitsur et al.

    Gender differences in the behavioral response to interleukin-1: neurochemical mechanisms

    Neuroimmunomodulation

    (1998)
  • Cited by (383)

    View all citing articles on Scopus
    View full text